ArticleCancers2026

Real-World Outcomes of Palbociclib with Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer: A Retrospective Study from Saudi Arabia.

Abdalrhman H Alanizi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.